Marketing-authorisation holder
Azurity Pharmaceuticals Ireland Limited
4 medicines in 3 countries, as authorisation holder.
Group structure
Part of
AzurityPharmaceutical groupOther companies in the group
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Alvesco 160 Inhalator, aërosol, oplossing 160 microgram/dosisAërosol, oplossing | Ciclesonide | Netherlands | Authorised | 2005 |
| ALVESCO 160 microgramos/INHALACION SOLUCION PARA INHALACION EN ENVASE A PRESION0,2 mg · Solución para inhalación en envase a presión | Ciclesonide | Spain | Marketed | 2009 |
| Alvesco 80 Inhalator, aërosol, oplossing 80 microgram/dosisAërosol, oplossing | Ciclesonide | Netherlands | Authorised | 2005 |
| DUAKLIR GENUAIR400 mcg / act + 12 mcg / act · Powder (Metered-Dose) | Aclidinium bromide, Formoterol | Canada | Marketed | 2015 |